**First-in-human (FIH)** studies are a critical step in the drug development process and typically aim to characterize a compound's pharmacokinetics, potential effective concentration or dose, and safety or tolerability margins. [Source](https://pubmed.ncbi.nlm.nih.gov/20671293/)